• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲基巯基咪唑、硫脲嘧啶和丙基硫脲嘧啶在体外对甲状腺过氧化物酶的不可逆失活作用及其与体内研究结果的关系。

The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings.

作者信息

Davidson B, Soodak M, Neary J T, Strout H V, Kieffer J D, Mover H, Maloof F

出版信息

Endocrinology. 1978 Sep;103(3):871-82. doi: 10.1210/endo-103-3-871.

DOI:10.1210/endo-103-3-871
PMID:744122
Abstract

A reinvestigation of the mechanism of action of methylmercaptoimidazole, propylthiouracil, and thiouracil on thyroid peroxidase (TPO) was undertaken. A preliminary incubation of TPO and H2O2 with methylmercaptoimidazole, propylthiouracil, or thiouracil was carried out in the absence of oxidizable substrates (i.e. I- or guaiacol). This incubation resulted in irreversible inactivation of TPO. The extent of inactivation could be determined after removal of the drug by gel filtration or by dilution into the assay mixture. Preincubation, as above, in the presence of iodide or thiocyanate prevented the irreversible inactivation of TPO. Rats receiving doses of these drugs which completely inhibited protein-bound iodine formation showed normal levels of TPO in their thyroid glands 30 min after drug administration. These findings suggest that the initial in vivo action of these drugs is to block iodination by trapping oxidized iodide, not by acting as "general inhibitors" of the TPO.

摘要

对甲巯基咪唑、丙硫氧嘧啶和硫氧嘧啶作用于甲状腺过氧化物酶(TPO)的作用机制进行了重新研究。在不存在可氧化底物(即碘离子或愈创木酚)的情况下,将TPO和过氧化氢与甲巯基咪唑、丙硫氧嘧啶或硫氧嘧啶进行预孵育。这种孵育导致TPO不可逆失活。通过凝胶过滤或稀释到测定混合物中去除药物后,可以确定失活程度。如上述在碘化物或硫氰酸盐存在下进行预孵育可防止TPO的不可逆失活。接受完全抑制蛋白结合碘形成剂量这些药物的大鼠在给药30分钟后甲状腺中TPO水平正常。这些发现表明,这些药物在体内的初始作用是通过捕获氧化碘来阻断碘化作用,而不是作为TPO的“一般抑制剂”起作用。

相似文献

1
The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings.甲基巯基咪唑、硫脲嘧啶和丙基硫脲嘧啶在体外对甲状腺过氧化物酶的不可逆失活作用及其与体内研究结果的关系。
Endocrinology. 1978 Sep;103(3):871-82. doi: 10.1210/endo-103-3-871.
2
Preferential inhibition of thyroxine and 3,5,3'-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin.丙硫氧嘧啶和甲巯咪唑在甲状腺过氧化物酶催化的甲状腺球蛋白碘化反应中对甲状腺素和3,5,3'-三碘甲状腺原氨酸形成的优先抑制作用。
Endocrinology. 1982 Jan;110(1):190-7. doi: 10.1210/endo-110-1-190.
3
Effect of antithyroid agents 6-propyl-2-thiouracil and 1-mehtyl-2-mercaptoimidazole on human thyroid iodine peroxidase.抗甲状腺药物6-丙基-2-硫氧嘧啶和1-甲基-2-巯基咪唑对人甲状腺碘过氧化物酶的作用。
J Clin Endocrinol Metab. 1976 Jul;43(1):152-8. doi: 10.1210/jcem-43-1-152.
4
Reversible and irreversible inhibition of thyroid peroxidase-catalyzed iodination by thioureylene drugs.硫脲类药物对甲状腺过氧化物酶催化碘化反应的可逆性和不可逆性抑制作用。
Endocrinology. 1983 Jan;112(1):86-95. doi: 10.1210/endo-112-1-86.
5
Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.硫脲类抗甲状腺药物在大鼠体内的作用机制:丙硫氧嘧啶可能使甲状腺过氧化物酶失活。
Endocrinology. 1983 Jul;113(1):362-70. doi: 10.1210/endo-113-1-362.
6
Thiourea and cyanamide as inhibitors of thyroid peroxidase: the role of iodide.硫脲和氰胺作为甲状腺过氧化物酶的抑制剂:碘化物的作用。
Endocrinology. 1979 Apr;104(4):919-24. doi: 10.1210/endo-104-4-919.
7
The mechanism of action of the thioureylene antithyroid drugs.硫脲类抗甲状腺药物的作用机制。
Endocrinology. 1976 Apr;98(4):1031-46. doi: 10.1210/endo-98-4-1031.
8
Methimazole and propylthiouracil increase cellular thyroid peroxidase activity and thyroid peroxidase mRNA in cultured porcine thyroid follicles.甲巯咪唑和丙硫氧嘧啶可增加培养的猪甲状腺滤泡中的细胞甲状腺过氧化物酶活性及甲状腺过氧化物酶信使核糖核酸。
Thyroid. 1999 May;9(5):513-8. doi: 10.1089/thy.1999.9.513.
9
Coupling of iodotyrosine catalyzed by human thyroid peroxidase in vitro.人甲状腺过氧化物酶体外催化碘酪氨酸的偶联反应。
J Clin Endocrinol Metab. 1985 Jun;60(6):1069-75. doi: 10.1210/jcem-60-6-1069.
10
Mechanism of inactivation of thyroid peroxidase by thioureylene drugs.硫脲类药物使甲状腺过氧化物酶失活的机制。
Biochem Pharmacol. 1982 Dec 1;31(23):3801-6. doi: 10.1016/0006-2952(82)90296-9.

引用本文的文献

1
Dihalogens Binding and Activation by Imidazoline-2-Chalcogenone Model Derivatives: Insight from a Computational Approach.咪唑啉-2-硫属羰基模型衍生物对二卤化物的结合与活化:计算方法的见解
Chemistry. 2025 Jun 6;31(32):e202500930. doi: 10.1002/chem.202500930. Epub 2025 May 8.
2
Transcriptomic landscape of hyperthyroidism in mice overexpressing thyroid-stimulating hormone.促甲状腺激素过表达小鼠甲状腺功能亢进的转录组图谱
iScience. 2024 Dec 10;28(1):111565. doi: 10.1016/j.isci.2024.111565. eCollection 2025 Jan 17.
3
Validation of a triiodothyronine (T3) ELISA for mouse fecal samples.
三碘甲状腺原氨酸(T3)ELISA 检测试剂盒在鼠粪样本中的验证。
Physiol Rep. 2024 Nov;12(21):e70115. doi: 10.14814/phy2.70115.
4
New Therapeutic Horizon of Graves' Hyperthyroidism: Treatment Regimens Based on Immunology and Ingredients From Traditional Chinese Medicine.格雷夫斯病甲亢的新治疗前景:基于免疫学和中药成分的治疗方案
Front Pharmacol. 2022 Apr 5;13:862831. doi: 10.3389/fphar.2022.862831. eCollection 2022.
5
Genetic and Neurological Deficiencies in the Visual System of Mutant Zebrafish.突变斑马鱼视觉系统的遗传和神经缺陷。
Int J Mol Sci. 2022 Feb 23;23(5):2464. doi: 10.3390/ijms23052464.
6
assays for characterization of distinct multiple catalytic activities of thyroid peroxidase using LC-MS/MS.使用液相色谱-串联质谱法对甲状腺过氧化物酶不同多重催化活性进行表征的测定
Curr Res Toxicol. 2021 Jan 12;2:19-29. doi: 10.1016/j.crtox.2021.01.001. eCollection 2021.
7
Management of Graves Thyroidal and Extrathyroidal Disease: An Update.格雷夫斯甲状腺和甲状腺外疾病的管理:更新。
J Clin Endocrinol Metab. 2020 Dec 1;105(12):3704-20. doi: 10.1210/clinem/dgaa646.
8
Antithyroid Drugs.抗甲状腺药物
Iran J Pharm Res. 2019 Fall;18(Suppl1):1-12. doi: 10.22037/ijpr.2020.112892.14005.
9
Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches.评估对甲状腺有干扰作用的化学物质:体外测试和不良结局途径方法的机遇和挑战。
Environ Health Perspect. 2019 Sep;127(9):95001. doi: 10.1289/EHP5297. Epub 2019 Sep 5.
10
Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Thiouracil Derivatives as Potential Antithyroid Agents.新型硫代尿嘧啶衍生物的设计、合成、分子模拟及作为潜在抗甲状腺药物的生物学评价。
Molecules. 2018 Nov 8;23(11):2913. doi: 10.3390/molecules23112913.